6 results for author:"Furci L." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor. Auerbach D.J., Lin Y., Miao H., Cimbro R., Difiore M.J., Gianolini M.E., Furci L., Biswas P., Fauci A.S., Lusso P. Proc. Natl. Acad. Sci. U.S.A. 109:9569-9574(2012) · Mapped (1) |
| Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. Brezzi B., Del Prete D., Lupo A., Magistroni R., Gomez-Lira M., Bernich P., Anglani F., Mezzabotta F., Turco A., Furci L. et al. J. Nephrol. 22:747-759(2009) · Mapped (9) |
| Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease. Magistroni R., Manfredini P., Furci L., Ligabue G., Martino C., Leonelli M., Scapoli C., Albertazzi A. J. Nephrol. 16:110-115(2003) · Mapped (19) |
| Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. Funk C.D., Furci L., Fitzgerald G.A., Grygorczyk R., Rochette C., Bayne M.A., Abramovitz M., Adam M., Metters K.M. J. Biol. Chem. 268:26767-26772(1993) · UniProtKB (1) |
| Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Funk C.D., Furci L., Moran N., Fitzgerald G.A. Mol. Pharmacol. 44:934-939(1993) · UniProtKB (1) |
| Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase. Funk C.D., Furci L., Fitzgerald G.A. Proc. Natl. Acad. Sci. U.S.A. 87:5638-5642(1990) · UniProtKB (1) |